Free Trial

Celcuity (CELC) Competitors

Celcuity logo
$11.21 +0.28 (+2.56%)
As of 04:00 PM Eastern

CELC vs. NHC, VRDN, AHCO, CDNA, AGL, PNTG, AVAH, CSTL, GRAL, and FLGT

Should you be buying Celcuity stock or one of its competitors? The main competitors of Celcuity include National HealthCare (NHC), Viridian Therapeutics (VRDN), AdaptHealth (AHCO), CareDx (CDNA), agilon health (AGL), The Pennant Group (PNTG), Aveanna Healthcare (AVAH), Castle Biosciences (CSTL), Grail (GRAL), and Fulgent Genetics (FLGT). These companies are all part of the "healthcare" industry.

Celcuity vs.

Celcuity (NASDAQ:CELC) and National HealthCare (NYSE:NHC) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their dividends, analyst recommendations, earnings, media sentiment, institutional ownership, community ranking, valuation, profitability and risk.

63.3% of Celcuity shares are owned by institutional investors. Comparatively, 56.4% of National HealthCare shares are owned by institutional investors. 15.8% of Celcuity shares are owned by company insiders. Comparatively, 13.8% of National HealthCare shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

National HealthCare has higher revenue and earnings than Celcuity. Celcuity is trading at a lower price-to-earnings ratio than National HealthCare, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CelcuityN/AN/A-$63.78M-$2.61-4.29
National HealthCare$1.14B1.35$66.80M$7.9812.53

Celcuity has a beta of 0.74, indicating that its share price is 26% less volatile than the S&P 500. Comparatively, National HealthCare has a beta of 0.46, indicating that its share price is 54% less volatile than the S&P 500.

Celcuity received 335 more outperform votes than National HealthCare when rated by MarketBeat users. However, 100.00% of users gave National HealthCare an outperform vote while only 67.54% of users gave Celcuity an outperform vote.

CompanyUnderperformOutperform
CelcuityOutperform Votes
337
67.54%
Underperform Votes
162
32.46%
National HealthCareOutperform Votes
2
100.00%
Underperform Votes
No Votes

Celcuity currently has a consensus target price of $29.17, indicating a potential upside of 160.58%. Given Celcuity's stronger consensus rating and higher possible upside, equities analysts plainly believe Celcuity is more favorable than National HealthCare.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Celcuity
0 Sell rating(s)
0 Hold rating(s)
6 Buy rating(s)
1 Strong Buy rating(s)
3.14
National HealthCare
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

National HealthCare has a net margin of 10.03% compared to Celcuity's net margin of 0.00%. National HealthCare's return on equity of 6.87% beat Celcuity's return on equity.

Company Net Margins Return on Equity Return on Assets
CelcuityN/A -62.66% -39.78%
National HealthCare 10.03%6.87%4.68%

In the previous week, Celcuity had 2 more articles in the media than National HealthCare. MarketBeat recorded 3 mentions for Celcuity and 1 mentions for National HealthCare. Celcuity's average media sentiment score of 1.01 beat National HealthCare's score of 0.00 indicating that Celcuity is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Celcuity
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
National HealthCare
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

Celcuity beats National HealthCare on 10 of the 18 factors compared between the two stocks.

Get Celcuity News Delivered to You Automatically

Sign up to receive the latest news and ratings for CELC and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CELC vs. The Competition

MetricCelcuityMedical laboratories IndustryMedical SectorNASDAQ Exchange
Market Cap$415.60M$3.05B$5.38B$9.11B
Dividend YieldN/A16.58%5.37%4.00%
P/E Ratio-4.2915.8087.8117.51
Price / SalesN/A206.401,285.9980.25
Price / CashN/A393.5036.6032.90
Price / Book2.045.144.944.66
Net Income-$63.78M-$33.85M$117.96M$224.69M
7 Day Performance6.30%7.15%2.29%3.11%
1 Month Performance-10.17%3.14%3.26%5.17%
1 Year Performance-24.17%19.81%27.03%22.24%

Celcuity Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CELC
Celcuity
2.5654 of 5 stars
$11.21
+2.6%
$29.17
+160.2%
-25.9%$416.23MN/A-4.3040Positive News
NHC
National HealthCare
N/A$97.01
+0.2%
N/AN/A$1.50B$1.23B12.1612,400
VRDN
Viridian Therapeutics
2.0473 of 5 stars
$17.77
-2.4%
$35.70
+100.9%
-9.8%$1.41B$302,000.00-4.1250
AHCO
AdaptHealth
3.7766 of 5 stars
$10.33
+1.9%
$12.40
+20.0%
+53.1%$1.39B$3.26B-6.2610,700Positive News
CDNA
CareDx
3.2033 of 5 stars
$25.07
+6.1%
$29.60
+18.1%
+131.8%$1.34B$312.78M-9.29740High Trading Volume
AGL
agilon health
2.4049 of 5 stars
$2.89
+18.9%
$3.98
+37.8%
-51.1%$1.19B$5.59B-3.07650Gap Up
PNTG
The Pennant Group
4.1067 of 5 stars
$26.23
+1.6%
$36.00
+37.2%
+74.8%$900.95M$652.30M38.575,791
AVAH
Aveanna Healthcare
0.9157 of 5 stars
$4.44
-1.6%
$4.51
+1.6%
+100.4%$857.92M$1.98B-13.0633,500
CSTL
Castle Biosciences
3.3396 of 5 stars
$26.15
-13.6%
$40.29
+54.1%
+30.2%$732.38M$311.88M130.76540Gap Up
High Trading Volume
GRAL
Grail
0.346 of 5 stars
$18.57
+4.7%
$16.00
-13.8%
N/A$623.97M$117.67M0.001,360
FLGT
Fulgent Genetics
3.6966 of 5 stars
$17.94
-2.0%
$22.00
+22.6%
-34.7%$548.73M$277.76M-3.251,010

Related Companies and Tools


This page (NASDAQ:CELC) was last updated on 1/21/2025 by MarketBeat.com Staff
From Our Partners